Finance Monthly M&A Awards Winners Edition

FINANCE MONTHLY M&A AWARDS 2020 17 MBA degree in Economics and Management. He has alsocompletedaPhDinHealthSciencesandTechnology at the Massachusetts Institute of Technology. From 2006 to 2012, Mr Hober was a postgraduate university teacher at the German Elite Academy in Freiberg, where he taught Health Economics. FIRM PROFILE Mergers & Acquisitions in Healthcare Performance overview ConAlliance is one of the leading European companies in the holistic support of company sales and acquisitions in the healthcare sector. The company also prepares due diligence reports and valuation reports, develops M&A strategies, market strategies, forecasts and assessments, and advises on restructuring and financing. Exclusively in Healthcare ConAlliance’s industry expertise focusses on the global healthcare system. Medical technology, pharmaceuticals, biotechnology, nursing and hospital systems and service companies in the health industry are among ConAlliance’s core competencies. For this purpose, ConAlliance has set up teams of specialists who, in addition to traditional investment banking, also stand out through detailed expert knowledge in their respective healthcare niches. Global network Through an international network, the firm offers advice and know-how on the global health markets, operating from Germany and having its own teams in London, Copenhagen, Chicago, Hong Kong, Tokyo, Seoul and Munich. Team The ConAlliance team knows the healthcare industry like no one else. It is equipped with an expert team of senior consultants and investment bankers who offer an in-depth insight into the pharmaceutical, medical device, medical product and life sciences markets, as well as strong research and clinical foundations. ABOUT GUNTER CARL HOBER Mr Gunter Carl Hober serves as a Managing Partner at ConAlliance, a company he co-founded. Numerous well-known mandates and transactions from leading healthcare companies are the guarantee for his professional M&A consulting services, which he implements with absolute discretion, the highest level of commitment and without conflicts of interest, exclusively for the benefit of his clients. Mr Hober’s expertise is limited to mergers and acquisitions in healthcare, comprising life sciences, pharmaceuticals, laboratories, medical services and medical devices. He is an expert in divestiture, acquisition planning, portfolio optimisation and partnering, deal structuring and valuation. Before founding ConAlliance Group, Mr Hober had gathered in-depth experience in investment banking and M&A advisory. Prior to that, he worked at one of the big five consulting firms, where he gained project and management experience with an emphasis on mergers and acquisitions and strategy development. Later, he became the Managing Director of a prominent Munich- based mergers and acquisitions boutique firm where he mandated numerous mergers and acquisitions deals and provided expert advice to medium-sized healthcare companies. Mr Hober studied Business Administration at the University of Regensburg in Germany and UCLA Anderson School of Management at the University of California in Los Angeles, USA, where he received his CONTACT T: +49 (89) 809 53 63- 0 W: www.conalliance.com